Effects of Smoking on Bone Health

Tobacco smoking exerts deleterious effects on skeletal health, reducing bone mass, impairing microarchitecture and prolonging fracture healing. Epidemiological evidence links both active and passive exposure to heightened risk of osteoporosis, vertebral and hip fractures, and delayed union following orthopaedic procedures. Mechanistically, tobacco constituents disrupt endocrine regulation—altering parathyroid hormone–vitamin D and sex hormone levels—while inducing oxidative stress, inflammation and an imbalance in bone remodelling through enhanced osteoclastogenesis and inhibited osteoblast function. Structural consequences include trabecular thinning, diminished matrix mineralisation and altered collagen composition. These changes carry global public health implications, contributing to morbidity in ageing populations and increasing healthcare resource utilisation. Smoking cessation alongside targeted interventions—such as antioxidants, anti-resorptive agents and modulators of key molecular pathways—offers practical strategies to preserve bone integrity and accelerate repair.

Research from Nature Portfolio

Recent studies have demonstrated that smokers exhibit elevated levels of inflammatory mediators in bone tissue, notably interleukin-1β, interleukin-6 and tumour necrosis factor-α, which correlate with increased osteoblast apoptosis and reduced collagen type I deposition. Histological analyses reveal a marked decrease in trabecular area exclusively in current smokers, suggesting a shift towards bone resorption. These findings refine our understanding of how smoking-induced inflammation precipitates cellular and matrix alterations that undermine bone strength, implicating persistent inflammatory signalling as a driver of fragility in both active and former smokers.

Effects of Smoking on Bone Health publication trend

The graph below shows the total number of articles in effects of smoking on bone health across all publications each year (not limited to Nature Index journals).

Technical terms

Osteoblast: A cell responsible for the synthesis and mineralisation of bone matrix.

Osteoclast: A cell that resorbs bone tissue during the remodelling process.

Bone remodelling: The continuous cycle of bone resorption and formation that maintains skeletal strength.

Pyroptosis: A caspase-dependent form of inflammatory programmed cell death.

RANKL–RANK–OPG pathway: A key molecular axis regulating osteoclast differentiation and activity.

Mesenchymal stem cell: A multipotent progenitor capable of differentiating into osteoblasts and other cell types.

Transforming growth factor β: A cytokine that modulates cell proliferation and differentiation during bone repair.

References

1. Smoking induces increased apoptosis in osteoblasts: changes in bone matrix organic components. Scientific Reports (2023).
2. Exploring the relationship between pyroptosis and inflammatory bone loss: Evidence from a cigarette smoke-induced osteoporosis mouse model. Heliyon (2024).
3. The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms. Journal of Osteoporosis (2018).
4. Cigarette Smoke Induces the Risk of Metabolic Bone Diseases: Transforming Growth Factor Beta Signaling Impairment via Dysfunctional Primary Cilia Affects Migration, Proliferation, and Differentiation of Human Mesenchymal Stem Cells. International Journal of Molecular Sciences (2019).